# Medium-Term Adjunctive Predictive Cardiovascular Indicator
> **Product code: QNL** · Class II — Moderate Risk (510(k) clearance required) · Cardiovascular · 21 CFR 870.2210
## Classification
- **FDA Product Code:** QNL
- **Device class:** Class II — Moderate Risk (510(k) clearance required)
- **Regulation:** 21 CFR 870.2210
- **Review panel:** CV
- **Medical specialty:** Cardiovascular
- **Submission type:** 1
- **GMP exempt:** N
- **Life sustaining:** N
- **Implant:** N
- **Third-party review:** N
## Definition

The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

## Market data
- **Cleared 510(k) submissions:** 5
- **Registered establishments:** 7
## Source
- [FDA Device Classification](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/classification.cfm?ID=QNL)
---
*AI Analytics · CC0 1.0*